| 1 |
Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients |
|
|
| Mohamed Hassan, Elsayed Z. Hatata, Mohamed Al-arman, Mohamed M. Aboelnaga |
|
| Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021; 15(4): 102152 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Is microvascular dysfunction a systemic disorder with common biomarkers found in the heart, brain, and kidneys? — A scoping review |
|
|
| Armin Nowroozpoor, David Gutterman, Basmah Safdar |
|
| Microvascular Research. 2021; 134: 104123 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
EVALUATION OF THE FUNCTIONAL STATE OF THE KIDNEYS IN HEALTHY AND PATIENTS WITH TYPE 1 DIABETES WITH DIFFERENT LEVELS OF ALBUMIN IN THE URINE |
|
|
| Yu. O. Kryvoviaz, V. S. Vernigorodskiy, L. ?. Cherkasova, O. P. Drachuk, Yu. V. Kordon |
|
| World of Medicine and Biology. 2021; 17(76): 064 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Diagnostic value of cystatin C for the early diagnosis of diabetic nephropathy |
|
|
| V. N. Vasilkova, I. Yu. Pchelin, E. P. Naumenka, Ya. A. Borovets, Yu. I. Yarets, L. E. Korotaeva, I. A. Vasukhina, T. V. Mokhort |
|
| Health and Ecology Issues. 2021; (2): 79 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Significance of Neutrophil Gelatinase-Associated Lipocalin as a Biomarker for the Diagnosis of Diabetic Kidney Disease: A Systematic Review and Meta-Analysis |
|
|
| Peng He, Ming Bai, Jin-ping Hu, Chen Dong, Shiren Sun, Chen Huang |
|
| Kidney and Blood Pressure Research. 2020; 45(4): 497 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Diagnostic Accuracy of Neutrophil Gelatinase-Associated Lipocalin for Predicting Early Diabetic Nephropathy in Patients with Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis |
|
|
| Georgia V Kapoula, Panagiota I Kontou, Pantelis G Bagos |
|
| The Journal of Applied Laboratory Medicine. 2019; 4(1): 78 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
